G6Pase/GAPDH cDNA levels tended to be higher in patients with NASH than in patients with simple steatosis without reaching statistical significance (1.42 ± 0.96 vs. 0.97 ± 0.58, p = 0.18). The gene discussed is G6PC1; the disease is metabolic dysfunction-associated steatohepatitis.